Wanbury Receives Key Safety and Workplace Recognitions for API Facilities
Wanbury Ltd 路 Press Release 路 19 Oct 2026, 8:11 pm
Wanbury Receives Key Safety and Workplace Recognitions for API Facilities Wanbury Limited announced that its Patalganga, Maharashtra API manufacturing site received the "Certificate of Excellence" from the National Safety Council for outstanding safety performance for the third consecutive year on 19th Oct'26. Additionally, its Tanuku, Andhra Pradesh API manufacturing facility was awarded the "Best Employer Award" by the Andhra Pradesh State Government for employee practices and workplace culture. Both USFDA and EUGMP-approved facilities support Wanbury鈥檚 global API supply chain across more than 50 export markets.
Original exchange filing (PDF)
More announcements from Wanbury Ltd
- Clarifications on investor queries regarding recent announcement 路 16 Nov 2026
- Wanbury Limited''s Tanuku Plant - US FDA Inspection - Updates 路 16 Nov 2026
- Wanbury Limited received regulatory approval (CADIFA: Letter of suitability for API) from ANVISA (Brazil FDA) for its flagship product Metformin HC1 EP grade. 路 12 Nov 2026
- Press Release on Standalone and Consolidated Un-audited Financial Results for the second quarter & half year ended 30th September, 2026. 路 06 Nov 2026
- Financial Results as on 30th September, 2026 路 05 Nov 2026
- Outcome of the Board Meeting held on November 04, 2026 路 05 Nov 2026
- Wanbury Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Wanbury Limited receives Australian TGA GMP Compliance Certificate for its Tanuku Plant, Strengthening Its Global Pharmaceutical Manufacturing Credentials. 路 30 Oct 2026
